Procter & Gamble Hygiene & Healthcare Ltd. - Research Center
500459 PGHH Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Jun ' 20 | Dec ' 19 | Dec ' 18 | Jun ' 18 | Dec ' 17 | |
|---|---|---|---|---|---|
| Sales | 1,290.58 | 1,711.41 | 1,609.87 | 1,093.54 | 1,361.75 |
| Operating profit | 234.84 | 368.87 | 400.79 | 217.71 | 397.68 |
| Interest | 3.47 | 2.60 | 0.90 | 4.44 | 0.88 |
| Gross profit | 255.44 | 386.31 | 435.11 | 226.71 | 407.43 |
| EPS (Rs) | 49.39 | 84.03 | 82.63 | 39.37 | 76.03 |
Half yearly
results in details
| Jun ' 20 | Dec ' 19 | Dec ' 18 | Jun ' 18 | Dec ' 17 | |
|---|---|---|---|---|---|
| Other income | 24.07 | 20.04 | 35.22 | 13.44 | 10.63 |
| Stock adjustment | -20.40 | 12.58 | -38.13 | 9.17 | 52.47 |
| Raw material | 442.18 | 624.03 | 473.00 | 248.31 | 296.52 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 88.30 | 84.99 | 72.73 | 57.04 | 58.19 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | 115.83 | 212.47 | 172.88 | 140.28 | 120.24 |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 415.95 | 408.47 | 528.60 | 421.03 | 436.65 |
| Provisions made | 13.88 | - | - | - | - |
| Depreciation | 24.95 | 22.93 | 24.41 | 26.01 | 26.36 |
| Taxation | 70.18 | 90.61 | 142.47 | 72.91 | 134.27 |
| Net profit / loss | 160.31 | 272.77 | 268.23 | 127.79 | 246.80 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 32.46 | 32.46 | 32.46 | 32.46 | 32.46 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 18.20 | 21.55 | 24.90 | 19.91 | 29.20 |
| GPM (%) | 19.43 | 22.31 | 26.45 | 20.48 | 29.69 |
| NPM (%) | 12.19 | 15.75 | 16.30 | 11.54 | 17.98 |
© 2020 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis